Stem Cell Sciences goes US
Wednesday, 04 March, 2009
Technology company Stem Cell Sciences (SCS) is to be sold to Delaware’s StemCells Inc for close to US$5 million.
SCS, which has a research laboratory in Melbourne and is headquartered in Cambridge in the UK, has an impressive portfolio of IP based around technologies for stem cell research including cell-based assays, gene delivery vehicles, cell media and methodologies.
In a statement, the companies said it was expected that SCS’s 20 full-time staff will be retained if the deal goes ahead. Agreement has already been received from 30 per cent of SCS shareholders.
An EGM to vote on the deal will be held in London on 27 March.
In the face of change: how Antarctic microbes can survive a 95°C temperature span
Analysis of microbial soil samples has helped Australian scientists understand the resilience of...
Sensor's cell-like structure said to overcome key blood-testing barrier
Drawing inspiration from nature, Australian researchers have developed a sensor they believe...
Revealed — a common bacterium's role in stubborn wound infections
A team of international researchers have uncovered how a common bacterium, Enterococcus...
